Defibrotide prophylaxis after HSCT did not reduce sinusoidal obstructive syndrome incidence in high-risk pediatric patients, per retrospective study at 2025 Tandem Meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback